In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong

Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use

(2013) Mette Charlot   ANNALS OF INTERNAL MEDICINE

Efficacy of dual antiplatelet therapy combined with Naoxintong Capsules (脑心通胶囊) following coronary microembolization induced by homologous microthrombi in rats

(2011) Huan Wang et al.   Chinese Journal of Integrative Medicine

Comparison of Adjunctive Naoxintong versus Clopidogrel in Volunteers with the CYP2C19*2 Gene Mutation Accompanied with Qi Deficiency and Blood Stasis Constitution

(2011) Hui Chen et al.   Evidence-based Complementary and Alternative Medicine

The Effect of St Johnʼs Wort on the Pharmacodynamic Response of Clopidogrel in Hyporesponsive Volunteers and Patients: Increased Platelet Inhibition by Enhancement of CYP3A4 Metabolic Activity

(2010) Wei C Lau et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

(2010) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The drug-drug interaction between proton pump inhibitors and clopidogrel

(2009) W. C. Lau et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

(2009) Alan R. Shuldiner   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Danqi Piantang Jiaonang (DJ), a Traditional Chinese Medicine, in Poststroke Recovery

(2009) Christopher Chen et al.   STROKE

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel

(2009) Dirk Sibbing et al.   THROMBOSIS AND HAEMOSTASIS

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

(2008) Martine Gilard et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

(2008) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE